Brought to you by 
Millennium Pharmaceuticals acquires ChemGenics in stock-deal
09 Apr 2001
Executive Summary
Millennium Pharmaceuticals (genomics for diagnostics and therapeutics) will acquire privately-held ChemGenics Pharmaceuticals (drug discovery) in a stock-swap transaction valued at about $89mm. ChemGenics had 1996 revenues of $3.6mm and a net loss of $12mm, according to a Millennium 8K.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Millennium Pharmaceuticals acquires ChemGenics in stock-deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice